Taro Pharmaceutical Industries Ltd. (TARO)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
As of 10:16AM EDT. Market open.
| Previous close | 42.41 |
| Open | 42.27 |
| Bid | 42.25 x 800 |
| Ask | 42.38 x 800 |
| Day's range | 42.26 - 42.28 |
| 52-week range | 28.10 - 45.76 |
| Volume | |
| Avg. volume | 42,658 |
| Market cap | 1.588B |
| Beta (5Y monthly) | 0.60 |
| PE ratio (TTM) | 34.64 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 10 Dec 2018 |
| 1y target est | N/A |
- Zacks
Amicus (FOLD) Banks on Galafold, Overdependence a Concern
Amicus' (FOLD) lead drug, Galafold, is witnessing solid uptake since its launch. The drug holds blockbuster potential. However, overdependence on Galafold for revenues remains a concern.
- Zacks
Iovance (IOVA) Falls After Clinical Update on Lung Cancer Drug
Iovance (IOVA) is likely to pause enrollment in the phase II IOV-LUN-202 study evaluating its tumor infiltrating lymphocyte therapy, LN-145, for treating non-small cell lung cancer. Stock declines.
- Zacks
Senti Bio (SNTI) Rises as FDA Clears IND for Cancer Candidate
The FDA clears Senti Bio's (SNTI) investigational new drug application for SENTI-202 for the treatment of relapsed/refractory hematologic malignancies, including acute myeloid leukemia. Stock rises.
© 2024 Yahoo. All rights reserved.